Pfizer
1 round tracked since 6 May 2026.
- Rounds
- 1
- Led
- 0
- Capital in these rounds
- $220M
Rounds
- CellCentricDevelops inobrodib, an oral p300/CBP inhibitor for multiple myeloma $220MSeries D · 6 May
No round matches these filters.
1 round tracked since 6 May 2026.
No round matches these filters.